Frontiers Outcome Measures in Clinical Trials of Patients With

Product Description

Frontiers Outcome Measures in Cancer Rehabilitation: Pain, Function, and Symptom Assessment

The PROTEUS-Trials Consortium: Optimizing the use of patient-reported outcomes in clinical trials - Claire Snyder, Norah Crossnohere, Madeleine King, Bryce B Reeve, Andrew Bottomley, Melanie Calvert, Elissa Thorner, Albert W Wu, Michael

Frontiers Consensus-Based Core Set of Outcome Measures for Clinical Motor Rehabilitation After Stroke—A Delphi Study

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Frontiers Outcome Measures in Cancer Rehabilitation: Pain, Function, and Symptom Assessment

Patient-Reported Outcomes Rethinking Clinical Trials®

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial - The Lancet Respiratory Medicine

Clinical Outcome Assessment, endpoints, AI

Cancers, Free Full-Text

Figure 4-1, Outcome Measures Framework - Registries for Evaluating Patient Outcomes: A User's Guide - NCBI Bookshelf

Disparities in Clinical Research and Cancer Treatment

Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial